These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 578033)
21. Thrombogenicity of factor IX concentrates: in vitro and in vivo (rabbit) studies. Cash JD; Owens R; Dalton RG; Prescott RJ Vox Sang; 1978; 35(1-2):105-10. PubMed ID: 664565 [TBL] [Abstract][Full Text] [Related]
22. Thrombogenicity of factor IX concentrates and polyethylene glycol processing. Foster PR; Patterson MR; Johnson AJ; Middleton SM Thromb Res; 1980 Jan 1-15; 17(1-2):273-9. PubMed ID: 7376134 [No Abstract] [Full Text] [Related]
23. New chromogenic peptide substrates for factor X. Aurell L; Simonsson R; Arielly S; Karlsson G; Friberger P; Claeson G Haemostasis; 1978; 7(2-3):92-4. PubMed ID: 658782 [TBL] [Abstract][Full Text] [Related]
24. The assay of factor Xa on a centrifugal analyzer. Gram J; Jespersen J; Sidelmann J Thromb Res; 1984 Jan; 33(2):239-42. PubMed ID: 6367133 [No Abstract] [Full Text] [Related]
25. The thrombogenicity of prothrombin complex concentrates and factor IX concentrates in vivo. Hampton KK Haemophilia; 1995; 2 Suppl 3():26-7. PubMed ID: 27213708 [No Abstract] [Full Text] [Related]
26. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin. Prowse CV; Boffa MC; Guthrie C; Pepper DS Thromb Haemost; 1980 Feb; 42(5):1368-77. PubMed ID: 7368144 [TBL] [Abstract][Full Text] [Related]
27. In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays. Prowse CV; Chirnside A; Elton RA Thromb Haemost; 1980 Feb; 42(5):1355-67. PubMed ID: 6768149 [TBL] [Abstract][Full Text] [Related]
28. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Ishikawa M; Kumashiro M; Yamazaki Y; Atoda H; Morita T J Biochem; 2009 Jan; 145(1):123-8. PubMed ID: 18977769 [TBL] [Abstract][Full Text] [Related]
29. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety. Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288 [TBL] [Abstract][Full Text] [Related]
30. Spectrophotometric determination of factor Xa generation in factor IX concentrates. Pepper DS; Banhegyi D; Howie A Thromb Haemost; 1977 Jun; 37(3):535-40. PubMed ID: 578033 [TBL] [Abstract][Full Text] [Related]
31. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Lämmle B; Griffin JH Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929 [TBL] [Abstract][Full Text] [Related]